Mixtard 30 (human insulin): marketing stopped after December 31st 2011

After December 31st 2011 Novo Nordisk stopped marketing the human insulin Mixtard 30 for commercial reasons. Mixtard 30 may be delivered in pharmacies while stocks last. Transition for a patient to another treatment should be under strict medical supervision.

See other languages (Frnech or Dutch)

Contact: info.medecines@fagg-afmps.be










Last updated on 18/01/2013